Allelic imbalance on chromosomes 13 and 17 and mutation analysis of BRCA1 and BRCA2 genes in monozygotic twins concordant for breast cancer

被引:14
作者
Försti, A [1 ]
Luo, L
Vorechovsky, I
Söderberg, M
Lichtenstein, P
Hemminki, K
机构
[1] Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden
[2] Huddinge Hosp, Dept Pathol, S-14186 Huddinge, Sweden
[3] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden
关键词
D O I
10.1093/carcin/22.1.27
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To study genetic changes associated with the development of breast cancer and the extent of its hereditary predisposition, paraffin-embedded tissue samples were obtained from monozygotic twin pairs concordant for breast cancer through the linked Swedish Twin and Cancer Registries. DNA samples extracted from the matched tumour and normal tissues of nine twin pairs were analysed for allelic imbalance using a series of microsatellite markers on chromosomes 13 and 17, containing loci with known tumour suppressor genes. Multiple losses of constitutional heterozygosity (LOH), consistent with a loss of large genomic region, the whole chromosome or chromosome arm, was found in at least three pairs of twins. One double mitotic crossover was identified in one tumour sample in a pair concordant for LOH at multiple loci on both chromosomes. Recombination breakpoints were mapped to regions delineated by D13S218 and D13S263, and D13S155 and D13S279, respectively, In general, no genetic effect of losing the same allele within a twin pair was found. However, for one marker at chromosome 13 (D13S328, between the BRCA2 and the Rb-1 loci) and two markers on chromosome 17 (D17S786, distal to the p53 locus, and D17S855, an intragenic BRCA1 marker) the proportion of twin pairs with the same LOH was significantly higher than expected. These regions may reflect hereditary genomic changes in our sample set. In addition, tumour DNA samples from a subset of 12 twin pairs were analysed for BRCA1 and BRCA2 mutations using exon-by-exon single-strand conformation polymorphism analysis. Two unclassified BRCA2 variants, with a putative pathogenic effect, were identified, but no pathogenic alterations were found in the BRCA1 gene.
引用
收藏
页码:27 / 33
页数:7
相关论文
共 46 条
[1]   Cancer in twins: Genetic and nongenetic familial risk factors [J].
Ahlbom, A ;
Lichtenstein, P ;
Malmstrom, H ;
Feychting, M ;
Hemminki, K ;
Pedersen, NL .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (04) :287-293
[2]   Multistep carcinogenesis of breast cancer and tumour heterogeneity [J].
Beckmann, MW ;
Niederacher, D ;
Schnurch, HG ;
Gusterson, BA ;
Bender, HG .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1997, 75 (06) :429-439
[3]  
BORG A, 1992, CANCER RES, V52, P2991
[4]   Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer:: correlation with disease characteristics [J].
Catteau, A ;
Harris, WH ;
Xu, CF ;
Solomon, E .
ONCOGENE, 1999, 18 (11) :1957-1965
[5]   LOSS OF HETEROZYGOSITY IN SPORADIC BREAST-TUMORS AT THE BRCA2 LOCUS ON CHROMOSOME 13Q12-Q13 [J].
CLETONJANSEN, AM ;
COLLINS, N ;
LAKHANI, SR ;
WEISSENBACH, J ;
DEVILEE, P ;
CORNELISSE, CJ ;
STRATTON, MR .
BRITISH JOURNAL OF CANCER, 1995, 72 (05) :1241-1244
[6]   EVIDENCE IMPLICATING AT LEAST 2 GENES ON CHROMOSOME-17P IN BREAST CARCINOGENESIS [J].
COLES, C ;
THOMPSON, AM ;
ELDER, PA ;
COHEN, BB ;
MACKENZIE, IM ;
CRANSTON, G ;
CHETTY, U ;
MACKAY, J ;
MACDONALD, M ;
NAKAMURA, Y ;
HOYHEIM, B ;
STEEL, CM .
LANCET, 1990, 336 (8718) :761-763
[7]   Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers [J].
Collins, N ;
Wooster, R ;
Stratton, MR .
BRITISH JOURNAL OF CANCER, 1997, 76 (09) :1150-1156
[8]  
CORNELIS RS, 1994, CANCER RES, V54, P4200
[9]   A comprehensive genetic map of the human genome based on 5,264 microsatellites [J].
Dib, C ;
Faure, S ;
Fizames, C ;
Samson, D ;
Drouot, N ;
Vignal, A ;
Millasseau, P ;
Marc, S ;
Hazan, J ;
Seboun, E ;
Lathrop, M ;
Gyapay, G ;
Morissette, J ;
Weissenbach, J .
NATURE, 1996, 380 (6570) :152-154
[10]  
Dobrovic A, 1997, CANCER RES, V57, P3347